ARCH Venture Partners XIII, LLC
董事
ARCH Venture Partners XIII, LLC is a corporate investment vehicle affiliated with ARCH Venture Partners and serves as a general partner entity for ARCH Venture Fund XIII, L.P., a Delaware limited partnership formed to invest in early‑stage biotechnology companies.[[5]](https://www.sec.gov/Archives/edgar/data/2006772/000101297524000050/xslFormDX01/primary_doc.xml)[[6]](https://www.stocktitan.net/sec-filings/KARD/form-3-kardigan-inc-initial-statement-of-beneficial-ownership-0817147a993b.html) As disclosed in Kardigan, Inc.’s Form 3 filing, ARCH Venture Partners XIII, LLC (“AVP XIII LLC”) acts as the general partner of ARCH Venture Fund XIII, L.P., which holds significant preferred stock and warrant positions in Kardigan, Inc. (KARD), reflecting its role as a strategic institutional investor rather than an operating company.[[5]](https://www.sec.gov/Archives/edgar/data/2006772/000101297524000050/xslFormDX01/primary_doc.xml)[[6]](https://www.stocktitan.net/sec-filings/KARD/form-3-kardigan-inc-initial-statement-of-beneficial-ownership-0817147a993b.html)
ARCH Venture Fund XIII, L.P., for which ARCH Venture Partners XIII, LLC serves as general partner, is a more than $3 billion venture capital fund announced in September 2024 to support the founding and growth of next‑generation biotechnology companies.[[1]](https://bioinformant.com/arch-venture-fund-3-billion/)[[3]](https://www.archventure.com/arch-venture-partners-announces-new-fund-xiii/)[[4]](https://www.prnewswire.com/news-releases/arch-venture-partners-announces-new-fund-to-create-the-next-generation-of-biotech-companies-302259298.html) The fund is managed under the broader ARCH Venture Partners platform, a Chicago‑based venture capital firm founded in 1986 that specializes in early‑stage life science and technology investments and operates through ARCH Venture Management LLC and affiliated general partner entities such as ARCH Venture Partners XIII, LLC.[[2]](https://en.wikipedia.org/wiki/Arch_Venture_Partners)[[3]](https://www.archventure.com/arch-venture-partners-announces-new-fund-xiii/)[[7]](https://www.archventure.com) Leadership and investment decisions for ARCH Venture Partners XIII, LLC and Fund XIII are overseen by ARCH’s senior partners, including Paul Berns, Kristina M. Burow, Keith Crandell, and Steven Gillis, who are identified in Kardigan’s insider disclosure as associated with the ARCH entities reporting beneficial ownership.[[6]](https://www.stocktitan.net/sec-filings/KARD/form-3-kardigan-inc-initial-statement-of-beneficial-ownership-0817147a993b.html)
查看完整内部人档案 →